RecruitingEarly Phase 1NCT05704283
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
3D Ultrasound Imaging of the Axillary Lymph Nodes
Sponsor
Mayo Clinic
Enrollment
55 participants
Start Date
Feb 14, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is evaluating whether 3D ultrasound can be used to better image lymph nodes in breast cancer patients. It aims to improve the accuracy of detecting whether cancer has spread to the lymph nodes, potentially offering an alternative to more invasive procedures.
**You may be eligible if...**
- You are 18 years or older
- You are a breast cancer patient who had a lymph node biopsy or had a clip placed in a lymph node as part of your standard care
**You may NOT be eligible if...**
- You are a prisoner or lack the mental capacity to give informed consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEUltrasound Imaging
Undergo 3D-US
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05704283
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589837 locations
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
NCT050568571 location
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NCT070671381 location
Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients
NCT0561210023 locations
Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma
NCT045626231 location